10-yr follow-up of a phase 3 RCT: chemoradiotherapy in muscle-invasive bladder cancer.
30 May, 2022 | 10:52h | UTC
Commentary on Twitter
Chemoradiotherapy in MIBC: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trialhttps://t.co/x8EFIoiqla@Prof_Nick_James @ProfSyedHussain @robert_huddart @NPortaStat
"Long-term findings confirm the benefit of adding 5-FU and MMC to RT for MIBC" pic.twitter.com/bKWSWhwemB
— European Urology (@EUplatinum) May 19, 2022